Embecta News

Embecta Analyst Ratings

BenzingaMay 10 11:37 ET

Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA) and Embecta Corporation (EMBC)

TipRanksApr 1 07:35 ET

Analysts Offer Insights on Healthcare Companies: McKesson (MCK), Embecta Corporation (EMBC) and Abbott Labs (ABT)

TipRanksFeb 12 05:50 ET

Analysts Offer Insights on Healthcare Companies: Embecta Corporation (EMBC), Mettler-Toledo (MTD) and Humacyte (HUMA)

TipRanksFeb 11 12:01 ET

Morgan Stanley Adjusts Price Target on to $16 From $15, Maintains Underweight Rating

MT NewswiresNov 22, 2023 09:42 ET

Embecta Analyst Ratings

BenzingaNov 22, 2023 08:33 ET

Embecta Corporation (EMBC) Receives a Hold From BTIG

TipRanksNov 21, 2023 11:55 ET

Analysts Offer Insights on Technology Companies: Cognizant (CTSH), Embecta Corporation (EMBC) and SolarEdge Technologies (SEDG)

TipRanksOct 20, 2023 04:30 ET

Morgan Stanley Maintains Underweight on Embecta, Lowers Price Target to $15

BenzingaOct 18, 2023 11:02 ET

Embecta Analyst Ratings

BenzingaOct 18, 2023 11:01 ET

BofA Trims Price Target on Embecta to $17 From $25, Keeps Underperform Rating

MT NewswiresOct 18, 2023 10:38 ET

Morgan Stanley Maintains Underweight on Embecta, Lowers Price Target to $16

BenzingaAug 24, 2023 09:32 ET

Embecta Analyst Ratings

BenzingaAug 24, 2023 09:27 ET

Embecta Corporation (EMBC) Gets a Sell From Bank of America Securities

TipRanksAug 10, 2023 05:15 ET

Morgan Stanley Adjusts Price Target on Embecta to $19 From $29, Maintains Underweight Rating

MT NewswiresJul 18, 2023 10:26 ET

Morgan Stanley Maintains Underweight on Embecta, Lowers Price Target to $19

BenzingaJul 18, 2023 10:07 ET

Embecta Analyst Ratings

BenzingaJul 18, 2023 10:06 ET

Analysts Offer Insights on Technology Companies: Embecta Corporation (EMBC), Fastly (FSLY) and Gitlab (GTLB)

TipRanksJun 23, 2023 06:31 ET

BTIG Sticks to Its Hold Rating for Embecta Corporation (EMBC)

TipRanksFeb 14, 2023 12:40 ET

Embecta Analyst Ratings

Benzinga Analyst RatingsJan 6, 2023 08:57 ET